Novo Nordisk expands its biopharm business with the acquisition of the US and Canadian rights to Macrilen (TM) Read more
Ionis Enters New Collaboration with Partner to Develop IONIS-FB-L Rx for Complement-Mediated Diseases Read more
Boehringer Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies Read more